Target intelligence / Profile preview

Tembusu virus envelope glycoprotein (TMUV-E)

Target
TMUV-E
Molecular classification
Viral surface protein, Flavivirus envelope protein, Glycoprotein
01

Overview

The Tembusu virus envelope glycoprotein (E protein) is the primary structural component on the surface of the Tembusu virus (TMUV) virion, a member of the Flaviviridae family. It plays a critical role in the viral life cycle by mediating attachment to host cell receptors and facilitating the fusion of the viral envelope with the host endosomal membrane during entry [1]. Structurally, the E protein is organized into three distinct domains (DI, DII, and DIII), with DIII being the primary site for receptor binding and a major target for neutralizing antibodies [2]. TMUV primarily affects waterfowl, causing significant economic losses in the poultry industry due to severe egg drop syndrome and neurological symptoms [3]. As the most immunogenic protein of the virus, the E protein is the central focus for the development of diagnostic tools, subunit vaccines, and therapeutic monoclonal antibodies aimed at blocking viral infection [4]. Experimental strategies targeting this protein include the use of RNA interference and small molecule inhibitors designed to disrupt its conformational changes required for fusion [5].

Other names
TMUV E proteinTembusu virus E proteinEnvelope protein EDuck Tembusu virus envelope proteinTMUV virion surface protein
02

Mechanism of action

Neutralization of viral entry by blocking receptor binding or inhibiting pH-dependent membrane fusion.

03

Biological functions

Viral entryReceptor bindingMembrane fusionViral assembly
04

Disease associations

Tembusu virus infectionDuck Tembusu virus diseaseAvian encephalitisEgg drop syndrome
05

Safety considerations

Antibody-dependent enhancement (ADE)Viral mutation and escapeCross-reactivity with other flaviviruses
06

Interacting drugs

Experimental monoclonal antibodies (e.g., 1G2, 1F2)

3 more in the full profile.

07

Biomarkers

Viral RNA loadE-protein specific neutralizing antibodiesHemagglutination inhibition (HI) titers

Beyond the preview

Go deeper on Tembusu virus envelope glycoprotein (TMUV-E).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tembusu virus envelope glycoprotein (TMUV-E).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call